Brief: Piramal Pharma, Newamsterdam Pharma Invest To Enhance Oral Solid Dosage Capabilities
21/08/2025 14:51
Aug 21 (Reuters) - Piramal Pharma Ltd PIRM.NS: PIRAMAL PHARMA LTD - CO, NEWAMSTERDAM PHARMA INVEST TO ENHANCE ORAL SOLID DOSAGE CAPABILITIES PIRAMAL PHARMA LTD - INVESTMENT EXPECTED TO CREATE MORE THAN 20 NEW JOBS AT SELLERSVILLE SITE Source text: ID:nBSEbp5P1k Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio